+49 30 648 35 164 service@chameleon-pharma.com

Changes in China’s medical system on the way

China’s government is reforming this huge nation’s healthcare system. The reform is mostly focused on the hospital sector but also affects other parts of the system.
The health care system and pricing in China are under close monitoring by the government. This will not change under the new reform; however, there will be increases in governmental healthcare for the urban poor and the rural population, who currently lack access to medical care or cannot afford it.

Healthcare subsidies are set to increase by 19% this year and the entire population of around one billion people should receive basic health care coverage within the next two years.
The government wants to create incentives for doctors in order to end the shortage of practitioners. Paying higher wages should improve the quality of doctors’ work. By employing more doctors it will also be possible to reach more people throughout the country and to provide them with improved healthcare.
Another governmental strategy for enhancing medical care is to reduce the size of public hospitals with the hope of encouraging the construction of additional hospitals. The aim is to spur competition among hospitals and incentivize them to operate efficiently.

Featured image: Photo by Aaron Greenwood on Unsplash

Contact us

2 + 3 =

Related Posts

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s large maternal care base continues to support demand for pregnancy supplements and women’s health products. According to INEGI, Mexico registered 1.67 million births in 2024, equal to 47.7 births per 1,000 women of fertile age. This creates regular demand for prenatal vitamins, folic acid, iron, calcium, DHA, and other Food Supplements supporting pregnancy, maternal wellbeing, and postpartum recovery.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis